Form 4: Tonix Pharmaceuticals Director Disposes of Fractional Share After Reverse Stock Split

A Tonix Pharmaceuticals director, Margaret Smith Bell, disposed of a fractional share of common stock due to an involuntary sale following a reverse stock split.

Summary

• On February 5, 2025, Margaret Smith Bell, a director of Tonix Pharmaceuticals Holding Corp., disposed of 1 share of common stock at a price of $0.15.
• The transaction was an involuntary sale of fractional shares resulting from a reverse stock split.
• The transaction was reported on February 28, 2025.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to a fractional share disposal, which is neutral in sentiment.

Industry Context

Form 4 filings are standard disclosures required by the SEC for insiders (directors, officers, and 10% owners) of publicly traded companies, providing transparency into their transactions in the company's stock.

Stakeholder Impact

• The impact on stakeholders is minimal, as the transaction involves a small number of shares resulting from a reverse stock split.

Key Dates